| Title： | Chinese Expert Consensus on Clinical Treatment of Severe Traumatic Brain Injury During the Epidemic of COVID-19 (Version 2023) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | medical personnel in Department of Neurosurgery,Department of Emergency,and ICU. |
| Evidence classification method： | According to the grading (grading of recommendations assessment, development and evaluation) system, the evidence level is divided into four grades: high, medium, low and very low. |
| Development unit： | Qilu Hospital of Shandong University |
| Registration time: | 2023-02-01 |
| Registration number： | PREPARE-2023CN059 |
| Purpose of the guideline: | Patients with severe traumatic brain injury and COVID-19 infection have complex conditions and many contradictions in the treatment, which brings difficulties to the clinical treatment. Since January 8, 2023, COVID-19 infection has been included in the management of Category B infectious diseases in China. Since then, the number of patients with severe traumatic brain injury combined with COVID-19 infection has increased correspondingly. In order to ensure the normalization and safety of clinical treatment for these patients, Critical Care Medicine Branch of China International Exchange and Promotive Association for Medical and Healthcare, and Editorial Board of Chinese Journal of Traumatology jointly led the formation of a consensus expert group to formulate this expert consensus. |
